AGIO
Agios PharmNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.04B
P/E Ratio
—
EPS
$-7.12
Beta
0.79
52W High
$46.00
52W Low
$22.24
50-Day MA
$28.88
200-Day MA
$33.78
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.47
PEG Ratio
0.00
About Agios Pharm
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $54.03M |
| Gross Profit (TTM) | $-291.85M |
| EBITDA | $-466.96M |
| Operating Margin | -609.00% |
| Return on Equity | -30.20% |
| Return on Assets | -19.90% |
| Revenue/Share (TTM) | $0.93 |
| Book Value | $20.41 |
| Price-to-Book | 1.73 |
| Price-to-Sales (TTM) | 37.74 |
| EV/Revenue | 23.1 |
| EV/EBITDA | -2.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 86.10% |
| Shares Outstanding | $58.59M |
| Float | $49.79M |
| % Insiders | 0.93% |
| % Institutions | 106.31% |
Analyst Ratings
Consensus ($43.75 target)
6
Buy3
HoldData last updated: 4/7/2026